MedTrace Logo

New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies

NCT06525688 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-07-29

No results posted yet for this study

Summary

This study aims to discover novel biomarkers and therapeutic targets for osteoporosis through the use of advanced omics technologies, including proteomics and metabolomics. By analyzing bone and plasma samples from patients with osteoporosis, the research seeks to understand the underlying mechanisms of the disease and identify potential diagnostic and therapeutic biomarkers.

Conditions

  • Osteoporosis, Postmenopausal
  • Osteoporosis Fracture
  • Osteoporosis, Severe

Interventions

OTHER

Bone, Serum and Plasma sample

Intervention: Bone samples will be collected during surgery from the femoral neck (which is typically removed and discarded in these operations) and fasting morning blood samples.

Sponsors & Collaborators

  • National Hellenic Research Foundation

    collaborator OTHER

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Efstathios Chronopoulos · KAT General Hospital, Athens Greece

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-03
Primary Completion
2024-10-15
Completion
2025-12-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06525688 on ClinicalTrials.gov